The Effectiveness of the Android Application as a Pharmaceutical Education Tool in Hypertensive Patients

August 13, 2023 updated by: Universitas Padjadjaran

The Influence of Android Application as a Pharmaceutical Education Tool on Knowledge, Adherence, Clinical Outcome and Quality of Life of Hypertension Prolanis Patients: A Pilot Study

Hypertension is a worldwide public health challenge due to its high prevalence and along with increased risk of complications of other diseases that are more dangerous if not managed properly. An estimated 1.4 billion people worldwide have high blood pressure, but only 14% can control it. Knowledge of hypertension in patients with hypertension can prevent complications through hypertension treatment. Increasing knowledge can be done by providing education in the form of counseling by pharmacists to hypertensive patients. Counseling activities carried out by pharmacists can be supported by a technological approach. One of the uses in smartphone technology is by creating an android-based mobile application that can be developed to support pharmaceutical care. Education conducted by pharmacists can increase knowledge that will affect hypertension treatment adherence, and this education can also improve blood pressure control so that it can improve the quality of life. The purpose of this study is to analyze the influence of the android application as a standard pharmacist education tool on knowledge as well as adherence and therapeutic outcomes of hypertensive patients, and quality of life related to the health of hypertensive patients compared to just providing standard education by pharmacists to hypertensive patients at the Primary Health Care. The method used in this study is a Quasi-Experimental with Pretest - Posttest Control Group Design. Samples were obtained by purposive sampling method at the selected Primary Health Care as the intervention group and the selected Primary Health Care as the control group. Pharmacist provides education to intervention groups with android applications as counseling aids and in control groups only standard counseling is provided. Pre-test data collection was done by taking primary and secondary data of patients at the first meeting and post-test data collection was taken prospectively through face-to-face interviews and questionnaires on hypertensive patients participants for three months by observing the influence of android applications as counseling aids on knowledge of hypertensive diseases, adherence to antihypertensive treatment, outcome therapy and quality of life.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Indonesia
    • Lampung
      • Bandar Lampung, Lampung, Indonesia
        • Health Centers

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients aged ≥ 18 years, male and female who are willing to be respondents.
  • Patients diagnosed with hypertension or currently taking ≥ 1 antihypertensive drug.
  • Hypertension patients who carry out routine control and receive anti-hypertensive drugs for at least 3 months at the Health Center.
  • Not illiterate and owns a smartphone.
  • Patients who are willing to participate in the study by signing an informed consent.

Exclusion Criteria:

  • Physical and mental disabilities such as deaf, blind, and psychiatric disorders.
  • The patient is pregnant
  • Currently taking hormonal drugs and other routine drugs such as TB, HIV and AIDS drugs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Pharmacy Education with Android Application as a Tool Conducted for Three Months in Hypertensive Patients to Improve Knowledge, Adherence, Outcome Therapy and Quality of Life
Device: Android Application
Android Application for 3 months
Behavioral: Pharmacy education
Pharmacy education in hypertensive patients
Active Comparator: Pharmacy education
Pharmacy education in hypertensive patients
Behavioral: Pharmacy education
Pharmacy education in hypertensive patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge about hypertension
Time Frame: At day 90 after treatment
Measured by Hypertension Knowledge-Level Scale (HK-LS) questionnaires
At day 90 after treatment
Adherence to antihypertensive treatment
Time Frame: At day 90 after treatment
Measurement by Medication Adherence Report Scale (MARS) questionnaires
At day 90 after treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure
Time Frame: 90 days
Measurement by blood pressure measuring device.
90 days
Quality of life related to the health
Time Frame: 90 days
Measurement by Short Form-36 (SF-36) questionnaires
90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universitas Padjadjaran

Investigators

  • Principal Investigator: Abdul K Tasib, S.Si., Apt., Faculty of Pharmacy Universitas Padjadjaran Bandung
  • Principal Investigator: Eli Halimah, Dr.M.Si.Apt., Faculty of Pharmacy Universitas Padjadjaran Bandung
  • Principal Investigator: Irma M Puspitasari, Prof.MT.Ph.D, Faculty of Pharmacy Universitas Padjadjaran Bandung

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 16, 2023

Primary Completion (Actual)

June 16, 2023

Study Completion (Actual)

June 16, 2023

Study Registration Dates

First Submitted

February 5, 2023

First Submitted That Met QC Criteria

February 5, 2023

First Posted (Actual)

February 15, 2023

Study Record Updates

Last Update Posted (Actual)

August 15, 2023

Last Update Submitted That Met QC Criteria

August 13, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pharm-202301.01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe